[Treatment response of a two-dose regimen of dose-adjusted inotuzumab ozogamicin in relapsed/refractory B-cell acute lymphoblastic leukemia]
[剂量调整的inotuzumab ozogamicin两剂方案治疗复发/难治性B细胞急性淋巴细胞白血病的疗效]
期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2023.11.005
An, L L; Zhao, D F; Hou, R F; Guan, H H; Yan, H; Lin, Y H; Tong, C R; Wu, T; Liu, S Y